2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
- PMID: 27216111
- DOI: 10.1016/j.jacc.2016.05.011
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Erratum in
-
Correction.J Am Coll Cardiol. 2016 Sep 27;68(13):1495. doi: 10.1016/j.jacc.2016.08.013. Epub 2016 Sep 19. J Am Coll Cardiol. 2016. PMID: 27659475 No abstract available.
Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides.
Comment in
-
Why to Replace an ACE or ARB With an ARB/Neprilysin Inhibitor?J Am Coll Cardiol. 2016 Nov 29;68(21):2390-2391. doi: 10.1016/j.jacc.2016.09.914. J Am Coll Cardiol. 2016. PMID: 27884259 No abstract available.
-
Reply: Why to Replace an ACE or ARB With an ARB/Neprilysin Inhibitor?J Am Coll Cardiol. 2016 Nov 29;68(21):2391. doi: 10.1016/j.jacc.2016.09.913. J Am Coll Cardiol. 2016. PMID: 27884260 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical